Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03319251 · ClinicalTrials.gov registry record
Biomarker Database Registry for Photodynamic Therapy
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 137
- Enrollment target
NCT03319251 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 137 participants.
The verdict
NCT03319251 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 137 participants
- Enrollment target
Study Summary
The purpose of this research is to obtain a blood sample from patients with actinic keratoses undergoing routine Photodynamic Therapy, in order to measure biomarkers that are relevant to VitD and 5FU metabolism and might be predictive of PDT outcome. The biomarkers to be examined include serum VitD levels at the time of PDT, and the presence/absence of gene alleles that correlate with expression of several proteins involved in VitD and 5FU metabolism. The presence of these biomarkers will be correlated to the improvement in AK lesion counts at the patient's routine follow-up visit 3 months after PDT treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2017-10-06 |
| Est. Completion | 2023-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03319251
The ClinicalTrials.gov registry entry for NCT03319251 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03319251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03319251 about?
NCT03319251 is a clinical study titled "Biomarker Database Registry for Photodynamic Therapy". The purpose of this research is to obtain a blood sample from patients with actinic keratoses undergoing routine Photodynamic Therapy, in order to measure biomarkers that are relevant to VitD and 5FU metabolism and might be predictive of PDT outcome. The biomarkers to be examined include serum VitD ...
What is the current status of trial NCT03319251?
This trial is currently completed. The enrollment target is 137 participants. The study started on 2017-10-06. Estimated completion is 2023-10-31.
Who is sponsoring clinical trial NCT03319251?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.